Literature DB >> 4426706

Live oral cholera vaccine: evaluation of the clinical effectiveness of two strains in humans.

R A Cash, S I Music, J P Libonati, A R Schwartz, R B Hornick.   

Abstract

El Tor Ogawa C14-S5 and EW-6, two live vaccine candidate strains, were given to volunteers in varying doses with and without bicarbonate. Vibrios were found in the stool of one of 32 men given the vaccine strain, and only three men developed a significant titer rise (fourfold or greater) at 2 weeks of vibriocidal or antitoxic antibody. Five men who had previously received 10(9) organisms of the C14-S5 strain were challenged subsequently with virulent Ogawa 395 Vibrio cholerae. The rate of clinical infection in these men was no different than in unvaccinated controls. It was demonstrated that the live oral cholera vaccines did not remain viable in the intestine long enough to act antigenically.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4426706      PMCID: PMC423019          DOI: 10.1128/iai.10.4.762-764.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  8 in total

1.  Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum.

Authors:  R A Cash; S I Music; J P Libonati; M J Snyder; R P Wenzel; R B Hornick
Journal:  J Infect Dis       Date:  1974-01       Impact factor: 5.226

2.  A prototype live oral cholera vaccine.

Authors:  B D Howard
Journal:  Nature       Date:  1971-03-12       Impact factor: 49.962

3.  Live oral cholera vaccine: report of a trial on human volunteer subjects.

Authors:  S C Sanyal; S Mukerjee
Journal:  Bull World Health Organ       Date:  1969-04       Impact factor: 9.408

4.  A controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in the Philippines.

Authors:  J C Azurin; A Cruz; T P Pesigan; M Alvero; T Camena; R Suplido; L Ledesma; C Z Gomez
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

5.  Production of antitoxic immunity by live oral cholera vaccine.

Authors:  P Bhattacharya; A Narayanaswami; S Mukerjee
Journal:  J Bacteriol       Date:  1968-01       Impact factor: 3.490

6.  Further studies on the development of a live oral cholera vaccine.

Authors:  P Bhattacharya; S Mukerjee
Journal:  J Hyg (Lond)       Date:  1968-06

7.  Titration of cholera antitoxin in human sera by microhemagglutination with formalinized erythrocytes.

Authors:  H D Hochstein; J C Feeley; W E DeWitt
Journal:  Appl Microbiol       Date:  1970-05

8.  PRELIMINARY STUDIES ON THE DEVELOPMENT OF A LIVE ORAL VACCINE FOR ANTI-CHOLERA IMMUNIZATION.

Authors:  S MUKERJEE
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

  8 in total
  4 in total

1.  Attenuation of virulence by P and V plasmids in Vibrio cholerae: strains suitable for oral immunization.

Authors:  V B Sinha; B S Srivastava
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

Review 2.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

3.  Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine.

Authors:  M M Levine; R E Black; M L Clements; C Lanata; S Sears; T Honda; C R Young; R A Finkelstein
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

4.  Cell surface characteristics of environmental and clinical isolates of Vibrio cholerae non-O1.

Authors:  K Chaudhuri; R K Bhadra; J Das
Journal:  Appl Environ Microbiol       Date:  1992-11       Impact factor: 4.792

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.